Our product
Lieberty logo
liberty product
liberty product

Our innovative solution elevates Gold Standard pathogen cultures by detecting and identifying pathogens through their gas biomarkers, streamlining laboratory workflows, eliminating contamination risks, reducing time to results and ensuring smooth lab integration.

Through our novel approach, we are transforming infectious diseases diagnostics using new gas biomarkers, focusing on key industrial and clinical markets to cut costs, reduce antibiotic use, and save lives.

Our solution promises rapid and precise diagnostics, paving the way for a new era of global health advancements.

Seamless integration in
laboratory workflow

Detection and identification of the
pathogen involved

No reagents required

Reduced contamination risks

Identification of pathogen gas biomarkers in culture bottles

No contact with culture media

Unmet medical need.

LABORATORY SETTINGS:

> Rapid pathogen detection and identification to deliver the adequate antibiotic therapy

> Simplification of Gold Standard pathogen culture, improving efficiency and accessibility in diagnostic testing

> No need for reagents, simplifying the testing process and reducing overall costs

> Use of standard culture bottles, enhancing the consistency and reliability of microbial testing



Disclaimer: Not CE-marked. Product not available on the market, not for sale.

Read more

Easy integration in the lab workflow






Detection of pathogens through their gas biomarkers


AI enhanced identification of the pathogen involved








Early detection through the application of volatolomics













Real-time Data Analytics















Diagnostic results on the lab network

Reduce antibiotic consumption

Address Antimicrobial Resistance (AMR)

Lower cost of care

Shorten time to result